Exolvo Biosciences

🗓 Founded 2024👥 2 employees💰 Last funded 2024
Biotechnology Research🌐 exolvobio.com
Website LinkedIn
Exolvo Biosciences is an innovative biotech company leading the way in transforming the oral delivery of large, complex molecules. Applying technology incubated within Verily/Google, Exolvo is committed to revolutionizing biologic drug delivery, making treatments more accessible and less invasive for patients. With a focus on pioneering solutions in an area that has seen limited advancements, Exolvo aims to improve patient outcomes and healthcare efficiency globally.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United Kingdom
1
Frequently asked questions
Who invested in Exolvo Biosciences?
Exolvo Biosciences has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Exolvo Biosciences last raise funding?
The most recent investment in Exolvo Biosciences recorded on gritt.io was in 2024.
When was Exolvo Biosciences founded?
Exolvo Biosciences was founded in 2024.
What industry is Exolvo Biosciences in?
Exolvo Biosciences operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.